For the Three Months ended March 31, 2020

(Unaudited)

As previously

Adjustment

As Restated

reported

Statement of Operations

Amortization and depreciation

$

           46,676

 $

           (46,676)

 $

                    -

Total Operating Expense

$

         335,472

 $

           (46,676)

 $

        288,796

Income/(Loss) from continuing operations before income taxes

$

           47,323

 $

            46,676

 $

          93,999

Net Income/(Loss)

$

             5,813

 $

            46,676

 $

          52,489

Net Income/(Loss) attributable to common stockholders

$

           (4,418)

 $

            46,676

 $

          42,258

Net Income/(Loss) per share – basic and diluted

Income/(Loss) from continuing operations

$

0.00

$

0.00

$

0.00

Income/(Loss) per common share - basic and diluted

$

(0.00)

$

0.00

$

0.00

For the Six Months ended March 31, 2020

(Unaudited)

As previously

Adjustment

As Restated

reported

Statement of Operations

Amortization and depreciation

$

           95,910

 $

           (85,032)

 $

          10,878

Total Operating Expense

$

         655,830

 $

           (85,032)

 $

        570,798

Income from continuing operations before income taxes

$

           33,565

 $

            85,032

 $

        118,597

Net Income/(Loss)

$

         (31,371)

 $

            85,032

 $

          53,661

Net Income/(Loss) attributable to common stockholders

$

         (51,946)

 $

            85,032

 $

          33,086

Net Income/(Loss) per share – basic and diluted

Income/(Loss) from continuing operations

$

(0.00)

$

0.00

$

0.00

Income/(Loss) per common share - basic and diluted

$

(0.00)

$

0.00

$

0.00

March 31, 2020

(Unaudited)

As previously

Adjustment

As Restated

reported

Statement of Changes in Stockholders’ Deficit

Additional Paid in Capital

$

    15,866,718

 $

         (600,000)

 $

   15,266,718

Accumulated Deficit

$

  (16,252,481)

 $

            85,032

 $

  (16,167,449)

Total Stockholders’ Deficit

$

       (383,436)

 $

         (514,968)

 $

       (898,404)

Total Liabilities and Stockholders’ Deficit

$

         753,103

 $

         (514,968)

 $

        238,135

March 31, 2020

(Unaudited)

As previously

Adjustment

As Restated

reported

Statement of Cash Flow

Net Income/(Loss)

$

         (31,371)

 $

            85,032

 $

          53,661

Amortization of ReadyMed software platform

$

           85,032

 $

(85,032)

 $

          -

Supplemental disclosures of non-cash investing and financing activities:

Common stock issued for ReadyMed platform

$

         600,000

 $

         (600,000)

 $

-